According to the experimental results in vitro, we speculate that Yangxinshi has a therapeutic effect on CF in DCM by regulating CBL pathway, promoting the expression of Cbl-b and inhibiting TGF- β/Smads pathway. The gene discussed is CBLB; the disease is cystic fibrosis.